Martin Kleman

Martin Kleman

Auto-generated profile, based on publicly available information

Martin Kleman

Alexion, AstraZeneca Rare Disease, Baar, Switzerland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2026 in Multiple Sclerosis Journal – Experimental, Translational and Clinical
Verified
Journal Article
Open access
SHSaif Huda
Saif Huda
MKMartin Kleman
Martin Kleman
KMKarl-Johan Myren
Karl-Johan Myren
MUMia Unsworth
Mia Unsworth
GCGiorgio Castellano
Giorgio Castellano
KFKristie Fitzmaurice
Kristie Fitzmaurice
Background: As knowledge is limited about the real-world impact of relapse among patients with neuromyelitis optica spectrum disorder (NMOSD), we aimed to assess the impact of relapse(s) on patient disability, clinical outcomes, and patient and caregiver burden in a real-world setting. Objective: To assess how NMOSD relapses impacts patient and caregiver burden. Methods: Data were drawn retrospectively from the Adelphi Real World NMOSD Disease Specific Programme, a cross-sectional survey of neurologists and patients with NMOSD patients in five European countries from January–June 2023. Neurologists reported patients’ demographics, caregiver involvement and clinical outcomes. Analyses were bivariate. Results: Overall, 99 neurologists provided data for 433 patients. In total, 128 patients had a relapse since their initial attack (1 relapse, 64.1%; 2 relapses, 18.8%; ≥ 3 relapses, 17.2%). Patients who had relapsed once had higher rates of control deficit for bladder (40.2% vs. 25.6%, p < . 001) and bowel (8.5% vs. 5.6%, p = . 042), which increased with additional relapses. Relapsed patients also required more caregiver support (41.4% vs. 31.1%, p = . 048), often their partner (41.4% vs. 31.1%, p = . 046). Conclusions: NMOSD relapse occurrence was associated with debilitating symptoms and more caregiver support, highlighting the need for more highly effective interventions to prevent patient and caregiver burden.